Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Apr;27(4):575-90.
doi: 10.1093/annonc/mdv590. Epub 2015 Dec 8.

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis

S G Smith  1 , I Sestak  2 , A Forster  3 , A Partridge  4 , L Side  5 , M S Wolf  6 , R Horne  7 , J Wardle  3 , J Cuzick  2
Affiliations
Meta-Analysis

Factors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysis

S G Smith et al. Ann Oncol. 2016 Apr.

Abstract

Background: Preventive therapy is a risk reduction option for women who have an increased risk of breast cancer. The effectiveness of preventive therapy to reduce breast cancer incidence depends on adequate levels of uptake and adherence to therapy. We aimed to systematically review articles reporting uptake and adherence to therapeutic agents to prevent breast cancer among women at increased risk, and identify the psychological, clinical and demographic factors affecting these outcomes.

Design: Searches were carried out in PubMed, CINAHL, EMBASE and PsychInfo, yielding 3851 unique articles. Title, abstract and full text screening left 53 articles, and a further 4 studies were identified from reference lists, giving a total of 57. This review was prospectively registered with PROSPERO (CRD42014014957).

Results: Twenty-four articles reporting 26 studies of uptake in 21 423 women were included in a meta-analysis. The pooled uptake estimate was 16.3% [95% confidence interval (CI) 13.6-19.0], with high heterogeneity (I(2) = 98.9%, P < 0.001). Uptake was unaffected by study location or agent, but was significantly higher in trials [25.2% (95% CI 18.3-32.2)] than in non-trial settings [8.7% (95% CI 6.8-10.9)] (P < 0.001). Factors associated with higher uptake included having an abnormal biopsy, a physician recommendation, higher objective risk, fewer side-effect or trial concerns, and older age. Adherence (day-to-day use or persistence) over the first year was adequate. However, only one study reported a persistence of ≥ 80% by 5 years. Factors associated with lower adherence included allocation to tamoxifen (versus placebo or raloxifene), depression, smoking and older age. Risk of breast cancer was discussed in all qualitative studies.

Conclusion: Uptake of therapeutic agents for the prevention of breast cancer is low, and long-term persistence is often insufficient for women to experience the full preventive effect. Uptake is higher in trials, suggesting further work should focus on implementing preventive therapy within routine care.

Keywords: adherence; chemoprevention; decision-making; medication; preventive therapy; uptake.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram of search strategy.
Figure 2.
Figure 2.
Meta-analysis of individual-level data for preventive therapy uptake by setting.
See this image and copyright information in PMC

Comment in

References

    1. Torre LA, Bray F, Siegel RL et al. . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2): 87–108. - PubMed
    1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014; 64(1): 52–62. - PubMed
    1. Autier P, Boniol M, LaVecchia C et al. . Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010; 341: c3620. - PMC - PubMed
    1. Kohler BA, Sherman RL, Howlader N et al. . Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 2015; 107(6): djv048. - PMC - PubMed
    1. Ferlay J, Héry C, Autier P, Sankaranarayanan R. Global burden of breast cancer. In: Li C. (ed). Breast Cancer Epidemiology. New York: Springer, 2010, 1–19.

Publication types

MeSH terms